
Professor of Pharmacology and Director of the Institute of Pharmacology of the University of Bern (Switzerland)
Hans-Uwe Simon is one of the leading international scientists in the field of the molecular mechanisms of inflammation, cell death, and carcinogenesis. His work in the domain of hypereosinophilic syndromes laid the foundations for a new classification of these conditions. Apart from that, with the direct participation of the researcher's group, an anti-eosinophilic drug, mepolizumab, was developed and registered as a medication. The drug is the first in its class. Among other achievements of Prof. Simon are the development of a new corticosteroid therapy method for eosinophilic esophagitis that is currently the main approach to the treatment of this disease.
Hosting organization
|
Field of studies
|
City
|
Invited researcher
|
Time span of the project
|
---|---|---|---|---|
Laboratory of Self-healing Construction Materials
Peter the Great St.Petersburg Polytechnic University |
Mechanics and machinery |
St. Petersburg |
Kordas Georgios
Greece |
2021-2023 |
Research Laboratory for the Mechanics of Bio-compatible Materials and Devices
Perm National Research Polytechnic University |
Mechanics and machinery |
Perm |
Silberschmidt Vadim
United Kingdom |
2021-2023 |
Laboratory of Digitalisation, Analysis and Synthesis of Complex Mechanical Systems, Networks and Environments
Institute for Problems in Mechanical Engineering of the Russian Academu of Sciences |
Mechanics and machinery |
St. Petersburg |
Fridman Emilia Moiseevna
Israel |
2021-2023 |